Laia Paré

Laia Paré

UNVERIFIED PROFILE

Are you Laia Paré?   Register this Author

Register author
Laia Paré

Laia Paré

Publications by authors named "Laia Paré"

Are you Laia Paré?   Register this Author

24Publications

-Reads

Coamplification of protects -amplified breast cancers from targeted therapy.

Proc Natl Acad Sci U S A 2018 03 23;115(11):E2594-E2603. Epub 2018 Feb 23.

Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, VCU School of Dentistry and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298;

View Article
March 2018

GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.

Cell Rep 2017 Nov;21(8):2183-2197

Glioma and Neural Stem Cell Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors Team, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. Electronic address:

View Article
November 2017

Corrigendum re: "TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer" [Eur Urol 2016;70:709-13].

Eur Urol 2017 08 1;72(2):e49. Epub 2017 Mar 1.

Translational Genomics and Targeted Therapeutics in Solid Tumours Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain. Electronic address:

View Article
August 2017

HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial.

Lancet Oncol 2017 04 24;18(4):545-554. Epub 2017 Feb 24.

Vall d'Hebron Institute of Oncology, Barcelona, Spain; Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. Electronic address:

View Article
April 2017

TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer.

Eur Urol 2016 11 2;70(5):709-713. Epub 2016 Mar 2.

Translational Genomics and Targeted Therapeutics in Solid Tumours Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain. Electronic address:

View Article
November 2016

Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer.

Bioinformatics 2016 04 24;32(7):1097-9. Epub 2015 Nov 24.

Bioinformatics and Computational Laboratory, Princess Margaret Cancer Centre, University Health Network and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

View Article
April 2016

Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer.

Clin Epigenetics 2015 24;7:74. Epub 2015 Jul 24.

Institute of Predictive and Personalized Medicine of Cancer (IMPPC, Ctra Can Ruti, Cami de les Escoles, Badalona, 08916 Spain.

View Article
July 2015

Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.

Int J Radiat Oncol Biol Phys 2011 Dec 11;81(5):1319-27. Epub 2011 May 11.

Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article
December 2011

Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil.

J Cancer Res Clin Oncol 2010 Nov 18;136(11):1681-9. Epub 2010 Feb 18.

Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Pare Claret 167, 08025 Barcelona, Spain.

View Article
November 2010

Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5-FU-based chemotherapy.

Br J Clin Pharmacol 2010 Aug;70(2):268-72

Departments of Genetics, de la Santa Creu i Sant Pau, Barcelona, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article
August 2010

Irinotecan pharmacogenetics: influence of pharmacodynamic genes.

Clin Cancer Res 2008 Mar;14(6):1788-96

Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

View Article
March 2008